Camzyos®▼(mavacamten) recommended for use on the NHS as an add-on treatment option for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM)
PharmiWeb,
Mavacamten has been recommended by the National Institute for Health and Care Excellence (NICE), as an add-on to individually…